What are exatecan drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

exatecan drugs are pharmacologic agents that share a common mechanism. 0 are currently marketed, with 1 more in clinical development.

exatecan

0 marketed 1 in Phase 3

This page covers all exatecan drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (1)

EXATECAN · Oncology
EXATECAN works by inhibiting topoisomerase I, an enzyme involved in DNA replication and repair.

Patent intelligence

exatecan patent landscape — aggregated cliff calendar, attackable patents, originator estates